Skip to main content
. 2019 Apr 9;10(5):1276–1279. doi: 10.1111/1759-7714.13065

Figure 2.

Figure 2

Free triiodothyronine (FT3), free thyroxine (FT4), and thyroid‐stimulating hormone (TSH) levels during pembrolizumab treatment. Thyroid hormone replacement therapy was initiated at the administration of the fifth course. Inline graphic FT3 (pg/mL), Inline graphic FT4 (ng/dL), Inline graphic TSH (μIU/mL)